Ramius Advisors’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-65,792
| Closed | -$3K | – | 108 |
|
|
2022
Q4 | $3K | Sell |
65,792
-30,000
| -31% | -$1.37K | ﹤0.01% | 89 |
|
|
2022
Q3 | $6K | Hold |
95,792
| – | – | ﹤0.01% | 147 |
|
|
2022
Q2 | $14K | Buy |
+95,792
| New | +$14K | 0.01% | 139 |
|
|
2022
Q1 | – | Sell |
-68,879
| Closed | -$35K | – | 132 |
|
|
2021
Q4 | $35K | Buy |
68,879
+56,479
| +455% | +$28.7K | 0.01% | 305 |
|
|
2021
Q3 | $7K | Buy |
+12,400
| New | +$7K | ﹤0.01% | 222 |
|